<?xml version="1.1" encoding="utf-8"?>
<article xsi:noNamespaceSchemaLocation="http://jats.nlm.nih.gov/publishing/1.1/xsd/JATS-journalpublishing1-mathml3.xsd" dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><front><journal-meta><journal-id journal-id-type="publisher-id">MRP</journal-id><journal-title-group><journal-title>Medical Research and Practice</journal-title></journal-title-group><issn>2993-9690</issn><eissn>2993-9704</eissn><publisher><publisher-name>Art and Technology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.61369/MRP.8050</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title>真人养脏汤核心成分治疗溃疡性结肠炎的网络药理学研究</title><url>https://artdesignp.com/journal/MRP/2/8/10.61369/MRP.8050</url><author>叶梦琪</author><pub-date pub-type="publication-year"><year>2024</year></pub-date><volume>2</volume><issue>8</issue><history><date date-type="pub"><published-time>2024-08-20</published-time></date></history><abstract>目的：采用网络药理学方法研究真人养脏汤治疗溃疡性结肠炎（UC）的作用机制。方法：在相关数据库中筛选真人养脏汤的有效成分和潜在靶点，构建化合物－靶点网络。然后筛选UC的靶点，得出共同的靶点，形成PPI网络用于预测核心的靶点。并对所得到的结果进行GO 和KEGG富集分析。结果：共预测了6种有效成分和77个共同靶点。山萘酚，&amp;Beta;-谷甾醇，玫瑰树碱，鞣花酸，豆固醇，异癸酸为药物关键有效活性成分，作用机制可能与癌症信号通路、脂质与动脉粥样硬化通路、化学致癌－受体激活通路、乙肝通路、人类疱疹病毒第四型感染通路、人类免疫缺陷病毒感染通路等信号通路有关。HSP90AA1、MAPK8、TNF、CASP3是UC治疗的关键靶点。结论。本研究体现了ZRYZ多成分、多靶点、多通路治疗溃疡性结肠炎的复杂网络关系，为治疗UC提供了思路。</abstract><keywords>溃疡性结肠炎 ,真人养脏汤 ,网络药理学</keywords></article-meta></front><body/><back><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><p>[1] Burri E, Maillard MH, Schoepfer AM, et al. Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update.Digestion. 2020;101 Suppl 1:2-15.doi:10.1159/000504092[2] Shen ZH, Zhu CX, Quan YS, et al. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.World J Gastroenterol. 2018;24(1):5-14. doi:10.3748/wjg.v24.i1.5[3] Yashiro M. Ulcerative colitis-associated colorectal cancer.World J Gastroenterol. 2014;20(44):16389-16397. doi:10.3748/wjg.v20.i44.16389[4] Du L, Ha C. Epidemiology and Pathogenesis of Ulcerative Colitis.Gastroenterol Clin North Am. 2020;49(4):643-654. doi:10.1016/j.gtc.2020.07.005[5] Yashiro M. Ulcerative colitis-associated colorectal cancer.World J Gastroenterol. 2014;20(44):16389-16397. doi:10.3748/wjg.v20.i44.16389[6] Guo M, Wang X. Pathological mechanism and targeted drugs of ulcerative colitis: A review. Medicine (Baltimore). 2023;102(37):e35020. doi:10.1097/MD.0000000000035020[7] Gros B, Kaplan GG. Ulcerative Colitis in Adults: A Review.JAMA. 2023;330(10):951-965. doi:10.1001/jama.2023.15389[8] Loftus EV Jr, Feagan BG, Panaccione R, et al. Long-term safety of vedolizumab for inflammatory bowel disease.Aliment Pharmacol Ther. 2020;52(8):1353-1365.doi:10.1111/apt.16060[9] Al-Abcha A, Raziq F, Kherallah S, Alratroot A. Mesalamine-induced eosinophilic pleural effusion.BMJ Case Rep. 2020;13(4):e233886. Published 2020 Apr 16. doi:10.1136/bcr-2019-233886[10] Wang M, Fu R, Xu D, et al. Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immunefunction attributed to ulcerative colitis through intestinal microecology. J Ethnopharmacol. 2024;318(Pt A):116879. doi:10.1016/j.jep.2023.116879[11] 王慧，毛晶磊，吴艳敏，王琪，罗晓庆，官杰．真人养脏汤对溃疡性结肠炎大鼠肠道黏膜屏障功能的保护作用［J］．中国病理生理杂志，2017,33(11):2053-2059.[12] 何青华．真人养脏汤合暖肝煎加减治疗溃疡性结肠炎（脾肾阳虚证）的临床研究［D］．长春中医药大学，2020.[13] 秦婧芬．二真汤治疗溃疡性结肠炎（脾肾阳虚证）的临床研究［D］．长春中医药大学，2018.[14] 王璐，刘冬梅．真人养脏汤合四逆汤治疗脾肾阳虚型溃疡性结肠炎40 例总结［J］．湖南中医杂志，2015,31(10):43-44.</p><pub-id pub-id-type="doi"/></element-citation></ref></ref-list></back></article>
